0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gonorrhea Diagnostics Market Research Report 2023
Published Date: February 2023
|
Report Code: QYRE-Auto-17S6171
Home | Market Reports | Health| Reproductive Health
Global Gonorrhea Diagnostics Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Gonorrhea Diagnostics Market Research Report 2023

Code: QYRE-Auto-17S6171
Report
February 2023
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Gonorrhea Diagnostics Market

Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae and can affect both genders. It is a common infection, especially among young people aged between 15 years to 24 years. According to the U.S. Centers for Disease Control and Prevention (CDC), gonorrhea is the second most commonly reported disease in the United States affecting approximately 800,000 people each year. In the United Kingdom, about 28,000 cases of gonorrhea are reported each year. Symptoms of gonorrhea in men encompass painful urination, swelling of testicles and pus discharge. In women, symptoms comprise excessive vaginal discharge, painful urination and abdominal pain. Complications include ectopic pregnancy, Pelvic Inflammatory Disease (PID) and Epididymitis. The incubation period for this disease also varies between men and women. In men, the symptoms occur between 2 to 14 days whereas in women it takes 7 days to 21 days to show symptoms. Astonishingly, about 50% of women have no symptoms in the early stage and during pregnancy it may infect the fetus during delivery.
The global Gonorrhea Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
There has been a recent rise in the incidences of gonorrhea across the globe due to the adoption of risky sexual behavior and unsafe sexual practices. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. The highest occurrence rates of gonorrhea are primarily in heterosexually infected men, especially those aged 25-34 years. These increasing incidences of gonorrhea will enhance the demand for gonorrhea diagnostic products during the forecast period.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gonorrhea Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gonorrhea Diagnostics.
The Gonorrhea Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gonorrhea Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gonorrhea Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Abbott Laboratories
  • Beckman Coulter
  • Roche Diagnostics
  • Siemens
  • bioMérieux
  • PerkinElmer
  • Ortho Clinical Diagnostics

Segment by Type

  • Chromatography
  • Diagnostic Imaging
  • Differential Light Scattering
  • Flow Cytometry
  • Gel Microdroplets
  • Immunoassay
  • Molecular Diagnostics
  • Monoclonal Antibodies Test

Segment by Application

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Clinics
  • Others

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gonorrhea Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Gonorrhea Diagnostics Market Report

Report MetricDetails
Report NameGlobal Gonorrhea Diagnostics Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gonorrhea Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chromatography
1.2.3 Diagnostic Imaging
1.2.4 Differential Light Scattering
1.2.5 Flow Cytometry
1.2.6 Gel Microdroplets
1.2.7 Immunoassay
1.2.8 Molecular Diagnostics
1.2.9 Monoclonal Antibodies Test
1.3 Market by Application
1.3.1 Global Gonorrhea Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Clinics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gonorrhea Diagnostics Market Perspective (2018-2029)
2.2 Gonorrhea Diagnostics Growth Trends by Region
2.2.1 Global Gonorrhea Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gonorrhea Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Gonorrhea Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Gonorrhea Diagnostics Market Dynamics
2.3.1 Gonorrhea Diagnostics Industry Trends
2.3.2 Gonorrhea Diagnostics Market Drivers
2.3.3 Gonorrhea Diagnostics Market Challenges
2.3.4 Gonorrhea Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gonorrhea Diagnostics Players by Revenue
3.1.1 Global Top Gonorrhea Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Gonorrhea Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Gonorrhea Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gonorrhea Diagnostics Revenue
3.4 Global Gonorrhea Diagnostics Market Concentration Ratio
3.4.1 Global Gonorrhea Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gonorrhea Diagnostics Revenue in 2022
3.5 Gonorrhea Diagnostics Key Players Head office and Area Served
3.6 Key Players Gonorrhea Diagnostics Product Solution and Service
3.7 Date of Enter into Gonorrhea Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gonorrhea Diagnostics Breakdown Data by Type
4.1 Global Gonorrhea Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Gonorrhea Diagnostics Forecasted Market Size by Type (2024-2029)
5 Gonorrhea Diagnostics Breakdown Data by Application
5.1 Global Gonorrhea Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Gonorrhea Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gonorrhea Diagnostics Market Size (2018-2029)
6.2 North America Gonorrhea Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gonorrhea Diagnostics Market Size by Country (2018-2023)
6.4 North America Gonorrhea Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gonorrhea Diagnostics Market Size (2018-2029)
7.2 Europe Gonorrhea Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gonorrhea Diagnostics Market Size by Country (2018-2023)
7.4 Europe Gonorrhea Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gonorrhea Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Gonorrhea Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gonorrhea Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Gonorrhea Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gonorrhea Diagnostics Market Size (2018-2029)
9.2 Latin America Gonorrhea Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gonorrhea Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Gonorrhea Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gonorrhea Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Gonorrhea Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gonorrhea Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Gonorrhea Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Gonorrhea Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Gonorrhea Diagnostics Introduction
11.2.4 Beckman Coulter Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.2.5 Beckman Coulter Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Gonorrhea Diagnostics Introduction
11.3.4 Roche Diagnostics Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.3.5 Roche Diagnostics Recent Development
11.4 Siemens
11.4.1 Siemens Company Detail
11.4.2 Siemens Business Overview
11.4.3 Siemens Gonorrhea Diagnostics Introduction
11.4.4 Siemens Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.4.5 Siemens Recent Development
11.5 bioMérieux
11.5.1 bioMérieux Company Detail
11.5.2 bioMérieux Business Overview
11.5.3 bioMérieux Gonorrhea Diagnostics Introduction
11.5.4 bioMérieux Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.5.5 bioMérieux Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Detail
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Gonorrhea Diagnostics Introduction
11.6.4 PerkinElmer Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.6.5 PerkinElmer Recent Development
11.7 Ortho Clinical Diagnostics
11.7.1 Ortho Clinical Diagnostics Company Detail
11.7.2 Ortho Clinical Diagnostics Business Overview
11.7.3 Ortho Clinical Diagnostics Gonorrhea Diagnostics Introduction
11.7.4 Ortho Clinical Diagnostics Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.7.5 Ortho Clinical Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Gonorrhea Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Chromatography
    Table 3. Key Players of Diagnostic Imaging
    Table 4. Key Players of Differential Light Scattering
    Table 5. Key Players of Flow Cytometry
    Table 6. Key Players of Gel Microdroplets
    Table 7. Key Players of Immunoassay
    Table 8. Key Players of Molecular Diagnostics
    Table 9. Key Players of Monoclonal Antibodies Test
    Table 10. Global Gonorrhea Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 11. Global Gonorrhea Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 12. Global Gonorrhea Diagnostics Market Size by Region (2018-2023) & (US$ Million)
    Table 13. Global Gonorrhea Diagnostics Market Share by Region (2018-2023)
    Table 14. Global Gonorrhea Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 15. Global Gonorrhea Diagnostics Market Share by Region (2024-2029)
    Table 16. Gonorrhea Diagnostics Market Trends
    Table 17. Gonorrhea Diagnostics Market Drivers
    Table 18. Gonorrhea Diagnostics Market Challenges
    Table 19. Gonorrhea Diagnostics Market Restraints
    Table 20. Global Gonorrhea Diagnostics Revenue by Players (2018-2023) & (US$ Million)
    Table 21. Global Gonorrhea Diagnostics Market Share by Players (2018-2023)
    Table 22. Global Top Gonorrhea Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonorrhea Diagnostics as of 2022)
    Table 23. Ranking of Global Top Gonorrhea Diagnostics Companies by Revenue (US$ Million) in 2022
    Table 24. Global 5 Largest Players Market Share by Gonorrhea Diagnostics Revenue (CR5 and HHI) & (2018-2023)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Gonorrhea Diagnostics Product Solution and Service
    Table 27. Date of Enter into Gonorrhea Diagnostics Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Gonorrhea Diagnostics Market Size by Type (2018-2023) & (US$ Million)
    Table 30. Global Gonorrhea Diagnostics Revenue Market Share by Type (2018-2023)
    Table 31. Global Gonorrhea Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 32. Global Gonorrhea Diagnostics Revenue Market Share by Type (2024-2029)
    Table 33. Global Gonorrhea Diagnostics Market Size by Application (2018-2023) & (US$ Million)
    Table 34. Global Gonorrhea Diagnostics Revenue Market Share by Application (2018-2023)
    Table 35. Global Gonorrhea Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 36. Global Gonorrhea Diagnostics Revenue Market Share by Application (2024-2029)
    Table 37. North America Gonorrhea Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. North America Gonorrhea Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 39. North America Gonorrhea Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Europe Gonorrhea Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Europe Gonorrhea Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Europe Gonorrhea Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Asia-Pacific Gonorrhea Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Asia-Pacific Gonorrhea Diagnostics Market Size by Region (2018-2023) & (US$ Million)
    Table 45. Asia-Pacific Gonorrhea Diagnostics Market Size by Region (2024-2029) & (US$ Million)
    Table 46. Latin America Gonorrhea Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 47. Latin America Gonorrhea Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 48. Latin America Gonorrhea Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 49. Middle East & Africa Gonorrhea Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 50. Middle East & Africa Gonorrhea Diagnostics Market Size by Country (2018-2023) & (US$ Million)
    Table 51. Middle East & Africa Gonorrhea Diagnostics Market Size by Country (2024-2029) & (US$ Million)
    Table 52. Abbott Laboratories Company Detail
    Table 53. Abbott Laboratories Business Overview
    Table 54. Abbott Laboratories Gonorrhea Diagnostics Product
    Table 55. Abbott Laboratories Revenue in Gonorrhea Diagnostics Business (2018-2023) & (US$ Million)
    Table 56. Abbott Laboratories Recent Development
    Table 57. Beckman Coulter Company Detail
    Table 58. Beckman Coulter Business Overview
    Table 59. Beckman Coulter Gonorrhea Diagnostics Product
    Table 60. Beckman Coulter Revenue in Gonorrhea Diagnostics Business (2018-2023) & (US$ Million)
    Table 61. Beckman Coulter Recent Development
    Table 62. Roche Diagnostics Company Detail
    Table 63. Roche Diagnostics Business Overview
    Table 64. Roche Diagnostics Gonorrhea Diagnostics Product
    Table 65. Roche Diagnostics Revenue in Gonorrhea Diagnostics Business (2018-2023) & (US$ Million)
    Table 66. Roche Diagnostics Recent Development
    Table 67. Siemens Company Detail
    Table 68. Siemens Business Overview
    Table 69. Siemens Gonorrhea Diagnostics Product
    Table 70. Siemens Revenue in Gonorrhea Diagnostics Business (2018-2023) & (US$ Million)
    Table 71. Siemens Recent Development
    Table 72. bioMérieux Company Detail
    Table 73. bioMérieux Business Overview
    Table 74. bioMérieux Gonorrhea Diagnostics Product
    Table 75. bioMérieux Revenue in Gonorrhea Diagnostics Business (2018-2023) & (US$ Million)
    Table 76. bioMérieux Recent Development
    Table 77. PerkinElmer Company Detail
    Table 78. PerkinElmer Business Overview
    Table 79. PerkinElmer Gonorrhea Diagnostics Product
    Table 80. PerkinElmer Revenue in Gonorrhea Diagnostics Business (2018-2023) & (US$ Million)
    Table 81. PerkinElmer Recent Development
    Table 82. Ortho Clinical Diagnostics Company Detail
    Table 83. Ortho Clinical Diagnostics Business Overview
    Table 84. Ortho Clinical Diagnostics Gonorrhea Diagnostics Product
    Table 85. Ortho Clinical Diagnostics Revenue in Gonorrhea Diagnostics Business (2018-2023) & (US$ Million)
    Table 86. Ortho Clinical Diagnostics Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gonorrhea Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Gonorrhea Diagnostics Market Share by Type: 2022 VS 2029
    Figure 3. Chromatography Features
    Figure 4. Diagnostic Imaging Features
    Figure 5. Differential Light Scattering Features
    Figure 6. Flow Cytometry Features
    Figure 7. Gel Microdroplets Features
    Figure 8. Immunoassay Features
    Figure 9. Molecular Diagnostics Features
    Figure 10. Monoclonal Antibodies Test Features
    Figure 11. Global Gonorrhea Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 12. Global Gonorrhea Diagnostics Market Share by Application: 2022 VS 2029
    Figure 13. Hospitals Case Studies
    Figure 14. Ambulatory Surgical Centers Case Studies
    Figure 15. Diagnostic Centers Case Studies
    Figure 16. Clinics Case Studies
    Figure 17. Others Case Studies
    Figure 18. Gonorrhea Diagnostics Report Years Considered
    Figure 19. Global Gonorrhea Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 20. Global Gonorrhea Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 21. Global Gonorrhea Diagnostics Market Share by Region: 2022 VS 2029
    Figure 22. Global Gonorrhea Diagnostics Market Share by Players in 2022
    Figure 23. Global Top Gonorrhea Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonorrhea Diagnostics as of 2022)
    Figure 24. The Top 10 and 5 Players Market Share by Gonorrhea Diagnostics Revenue in 2022
    Figure 25. North America Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. North America Gonorrhea Diagnostics Market Share by Country (2018-2029)
    Figure 27. United States Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Canada Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Europe Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Europe Gonorrhea Diagnostics Market Share by Country (2018-2029)
    Figure 31. Germany Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. France Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. U.K. Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Italy Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Russia Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Nordic Countries Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Asia-Pacific Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Asia-Pacific Gonorrhea Diagnostics Market Share by Region (2018-2029)
    Figure 39. China Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Japan Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. South Korea Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Southeast Asia Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. India Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Australia Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Latin America Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Latin America Gonorrhea Diagnostics Market Share by Country (2018-2029)
    Figure 47. Mexico Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Brazil Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Middle East & Africa Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Gonorrhea Diagnostics Market Share by Country (2018-2029)
    Figure 51. Turkey Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Gonorrhea Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Abbott Laboratories Revenue Growth Rate in Gonorrhea Diagnostics Business (2018-2023)
    Figure 54. Beckman Coulter Revenue Growth Rate in Gonorrhea Diagnostics Business (2018-2023)
    Figure 55. Roche Diagnostics Revenue Growth Rate in Gonorrhea Diagnostics Business (2018-2023)
    Figure 56. Siemens Revenue Growth Rate in Gonorrhea Diagnostics Business (2018-2023)
    Figure 57. bioMérieux Revenue Growth Rate in Gonorrhea Diagnostics Business (2018-2023)
    Figure 58. PerkinElmer Revenue Growth Rate in Gonorrhea Diagnostics Business (2018-2023)
    Figure 59. Ortho Clinical Diagnostics Revenue Growth Rate in Gonorrhea Diagnostics Business (2018-2023)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS